drugset / Trial / NCT00741949

Broncho-alveolar Lavage Under Noninvasive Ventilation With Propofol TCI in Patient With AHRF

NCT00741949

Phase 3 Completed 46 enrolled University Hospital, Bordeaux
RandomizedParallel-groupTriple-blindSupportive care

Summary

Fiberoptic bronchoscopy (FOB) is an important tool for the diagnosis of pulmonary diseases, more particularly in infectious pneumonia. In patients with severe acute hypoxemic respiratory failure, FOB may be contra-indicated until the patient is intubated and control of its oxygenation obtained. In the literature several authors showed that performing FOB under non invasive ventilation (NIV) preserved oxygenation of the patient; and the recent French Consensus on NIV recommends performing FOB under NIV in patients with acute hypoxemic respiratory failure. Nevertheless this procedure remains uncomfortable in most patients with respiratory failure. In addition, patient's agitation may lead to desaturation, and compromise the realization of FOB.

Timeline

Start
2008-09
Primary completion
2011-06
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Propofol Small molecule